GSK plc (GLAXF) stock
GLAXFOTCPharmaceutical PreparationsAlso trades as GSK
Financials through fiscal 2025, year ended Dec 31, 2025Score 9/30
$24.74+0.30 (+1.21%)
Close on Oct 19, 2026Market cap $106.83BP/E 13.3Yield –
GSK shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
For fiscal 2025 it was 4.12B, down 0.6% from the year before. Over ten years it grew 0.5% a year on average. The highest annual figure on record is 4.14B in fiscal 2024.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4.12B | -0.6% |
| FY2024 | Dec 31, 2024 | 4.14B | +0.8% |
| FY2023 | Dec 31, 2023 | 4.11B | +0.7% |
| FY2022 | Dec 31, 2022 | 4.08B | +0.8% |
| FY2021 | Dec 31, 2021 | 4.05B | +0.5% |
| FY2020 | Dec 31, 2020 | 4.03B | +0.4% |
| FY2019 | Dec 31, 2019 | 4.01B | +0.9% |
| FY2018 | Dec 31, 2018 | 3.98B | +0.6% |
| FY2017 | Dec 31, 2017 | 3.95B | +0.7% |
| FY2016 | Dec 31, 2016 | 3.93B | +0.4% |
| FY2015 | Dec 31, 2015 | 3.91B | – |